Login
$ELAN
$22.65 -$0.31 (1.35%) Close

$ELAN 3 SEC Filings

Filed On Filing
14 Jul 2025 Form 3: VanHimbergen Robert M, EVP and CFO

Holds 7,426 shares of Common Stock

19 Nov 2024 Form 3: Ma Stacey, Director

No securities owned

08 Apr 2024 Form 3: Turner Kathy V, Director

No securities owned

08 Apr 2024 Form 3: Wallace Craig S., Director

No securities owned

27 Nov 2023 Form 3: O'Neill Shiv, Interim GC and Corp Sec

Holds 8,789 shares of Common Stock

05 Jul 2023 Form 3: McArdle Grace, EVP, MANUFACTURING AND QUALITY

Holds 22,377 shares of Common Stock

24 Mar 2023 Form 3: Bettington Timothy J, See remarks

No securities owned

05 Apr 2022 Form 3: Modi Rajeev A., See Remarks

No securities owned

04 Nov 2021 Form 3: de Brabander Ellen, See Remarks

No securities owned

25 Jun 2021 Form 3: Elanco Animal Health Inc, 10% owner · Kindred Biosciences, Inc.

Holds 0 shares of Common Stock, par value $0.0001

24 Jun 2021 Form 3: Kirberger Marcela A., Ex VP, Gen Counsel & Corp Sec

No securities owned

23 Dec 2020 Form 3: Ferguson Scott D., Director and 3 others

Holds 27,835,500 shares of Common Stock, no par value ("Shares")

21 Dec 2020 Form 3: Doyle William F, Director

No securities owned

21 Dec 2020 Form 3: Herendeen Paul, Director

No securities owned

11 Aug 2020 Form 3: Ehle Dirk, Ex VP & Pres Elanco Europe

No securities owned

11 Aug 2020 Form 3: Lee Joyce J., Ex VP, Prs US Pet Hlth Com Op

No securities owned

03 Aug 2020 Form 3: Bayer Aktiengesellschaft, 10% owner and 1 other

Holds 72,946,429 shares of Common Stock

27 Apr 2020 Form 3: Correia de Simas Jose Manuel, EVP, US Farm Animal Business

No securities owned

27 Apr 2020 Form 3: Mason Racquel Harris, EVP, Chief Marketing Officer

No securities owned

15 May 2019 Form 3: Garcia Art A, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support